24 May 2019

Three researchers from RIMLS are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO (The Netherlands Organisation for Scientific Research) is awarding the Vidi grant as part of the Innovational Research Incentives Scheme.

Vidi is aimed at excellent researchers who have been producing successful research for a number of years since obtaining their PhD. These academics are among the best 10 to 20 percent in their field. A Vidi will allow them to conduct research for a period of five years. In this way, NWO stimulates curiosity-driven and innovative research.

We congratulate our researchers with this funding and wish them a lot of success with their great work.

Matthijs Jore, Dept. of Medical Microbiology, theme Infectious diseases and global health

Project: The malaria parasite’s fight against our immune system
Malaria is caused by unicellular parasites that are transmitted by mosquitoes. This research project studies at a molecular level how malaria parasites can evade the human immune system. The obtained insight will be used to develop novel drugs and vaccines against malaria.

Daniele Tauriello, Dept. of Cell Biology, theme Tumors of the digestive tract
Project: Restoring the immune system to prevent cancer from spreading
White blood cells can kill spreading cancer cells but are frequently sidelined by the tumour. The researchers will dissect this process of immune evasion in cultured minitumours to then block it in colon cancer in mice. With this treatment option, they may be able to prevent or cure metastasis.

Johannes Textor, Dept. of Tumor Immunology, theme Cancer development and immune defense
Project: How Intelligent is the Immune System?
Like our brain, our immune system can learn. The researchers will build computer models of the immune system and train these to recognize text and images to understand how the system learns, forgets, and gets confused. This will help to design therapies that use the immune system, such as vaccines.


Related news items

Radboudumc researchers publish new insights into COVID-19 Consequences for treatment are now being examined internationally

10 April 2020

Researchers at the Radboud university medical center seem to have found an essential mechanism in the disease process of Covid-19, which has so far been overlooked. If the insight is correct, it probably has important consequences for the treatment of the disease.

read more

Stuttering DNA orchestrates the start of the mosquito’s life

9 April 2020

A certain type of junk DNA that is found in mosquitoes and which repeats itself dozens of times, known as ‘satellite DNA’, has now been shown to play an essential role in the early development of mosquito embryos. Ronald van Rij and colleagues published their findings in Nature.  

read more

Webinar for researchers 20 April 17:00 hrs

9 April 2020

The corona crisis has an impact on our research every day. Therefore we organize a webinar specifically aimed at researchers. Do you have specific topics or questions that you would like to see reflected in the webinar? Let us know via research@radboudumc.nl.

read more

Gut microbiota from AD(H)D patients affects mice brain

8 April 2020

In a recent study, published in the journal Microbiota, Radboudumc researchers showed that gut microbiota from AD(H)D patients can cause brain alterations in mice.

read more

The ICI Amsterdam-Leiden-Nijmegen cancer vaccine consortium

7 April 2020

The Chemical Immunology group from Martijn Verdoes, theme Nanomedicine, joined forces with two Organic Chemistry groups and a Chemical Biology group from Leiden University, and Immunology groups at the AmsterdamUMC and the LUMC to form a consortium to develop new cancer vaccines.

read more

Martinus van Marum prize for Tom Schirris

3 April 2020

This award of € 12,500 is intended as an incentive prize for researchers who have obtained their PhD degree in 2015 or later. The jury, consisting of members of the Society, came to this decision unanimously.

read more